Clinical residual symptomatology and associated factors in multiple organ failure survivors: A long-term mortgage
Related Experiment Videos
S Rodríguez-Villar1, J L Rodríguez-García2, J Arévalo-Serrano3
1Critical Care Department, King's College Hospital, London, Reino Unido.
Purpose:
To evaluate which residual clinical symptoms multi-organ failure (MOF) patients may exhibit post discharge from Intensive Care Units (ICU) and to identify the associated factors that cause such symptoms.
Material And Methods:
A total of 545 adult patients admitted to a medical & surgical ICU in Spain diagnosed with MOF on admission were included in the study. Follow up in the form of a telephone survey regarding the patients clinical symptoms were conducted at 6 and 12 months after discharge from ICU.
Results:
A total of 266 patients were followed up at both 6 and 12 months post ICU discharge; 62.2% were male; age 60±18 years; 67.8% medical patients. The most common symptoms to appear following hospital discharge included: asthenia (173; 76%), sleep disturbances (112; 50%) and depression (109; 48%).
Conclusions:
The study revealed frequent residual clinical symptoms persisting for almost a year post ICU discharge, most notably arthromyalgia and asthenia. Depression symptoms during the first 6 months post-hospital discharge were also common among multiple organ failure survivors. The presence of symptomatology over time was found to be related to a poor functional situation at 6 and12 months post ICU discharge, length of hospital stay and severity of illness score on ICU admission.
Insights
Multi-organ failure (MOF) survivors frequently experience persistent symptoms like asthenia and depression for up to a year after intensive care unit (ICU) discharge. These long-term symptoms are linked to functional decline and initial illness severity.
Area of Science:
- Critical Care Medicine
- Post-Intensive Care Syndrome Research
- Clinical Symptomatology Studies
Background:
- Multi-organ failure (MOF) is a critical condition requiring intensive care unit (ICU) admission.
- Understanding residual symptoms post-ICU is crucial for patient recovery and long-term health outcomes.
- Limited data exists on the specific long-term clinical manifestations following MOF.
Purpose of the Study:
- To identify residual clinical symptoms in patients after discharge from the Intensive Care Unit (ICU) following multi-organ failure (MOF).
- To determine factors associated with the development and persistence of these post-discharge symptoms.
Main Methods:
- A cohort of 545 adult patients with MOF on admission to a medical & surgical ICU in Spain was studied.
- Telephone surveys were conducted at 6 and 12 months post-ICU discharge to assess clinical symptoms.
- Data analysis focused on symptom prevalence and associated factors.
Main Results:
- Of 266 patients followed up, common symptoms included asthenia (76%), sleep disturbances (50%), and depression (48%).
- Arthromyalgia and asthenia were the most frequent persistent symptoms observed up to one year post-ICU discharge.
- Depression was also prevalent within the first six months after hospital discharge.
Conclusions:
- Significant residual clinical symptoms persist for nearly a year in MOF survivors, with asthenia being particularly common.
- The persistence of symptoms is associated with poorer functional status at 6 and 12 months, longer hospital stays, and higher initial illness severity.
- Early identification and management of these long-term symptoms are essential for improving recovery trajectories in MOF patients.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury III: Clinical Manifestations
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Heart Failure III: Clinical Manifestations
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia III: Complications and Assessment